Valproic acid induced neural tube defects in mouse and human: Aspects of chirality, alternative drug development, pharmacokinetics and possible mechanisms
H. Nau, R.-S. Hauck, and K. Ehlers Valproic acid induced neural tube defects in mouse and human: aspects of chirality, alternative drug development, pharmacokinetics and possible mechanisms Pharmacol. Toxicol. 69 1991 310 321
Differentiation between valproate-induced anticonvulsant effect, teratogenicity and hepatotoxicity
H. Nau, and H. Siemens Differentiation between valproate-induced anticonvulsant effect, teratogenicity and hepatotoxicity Pharm. Weekbl. Sci. 14 1992 101 105
Further branching of valproate-related carboxylic acids reduces the teratogenic activity, but not the anticonvulsant effect
U. Bojic, M.M.A. Elmazar, R.-S. Hauck, and H. Nau Further branching of valproate-related carboxylic acids reduces the teratogenic activity, but not the anticonvulsant effect Chem. Res. Toxicol. 9 1996 866 870
Influence of 5-(3-chlorophenyl)-4-(4-methylphenyl)-2,4-dihydro-3H-1,2,4- triazole-3-thione on the anticonvulsant action of four classical antiepileptic drugs in the mouse maximal electroshock-induced seizure model
J.J. Luszczki, T. Plech, and M. Wujec Influence of 5-(3-chlorophenyl)-4- (4-methylphenyl)-2,4-dihydro-3H-1,2,4-triazole-3-thione on the anticonvulsant action of four classical antiepileptic drugs in the mouse maximal electroshock-induced seizure model Pharmacol. Rep. 64 2012 970 978
Effect of 4-(4-bromophenyl)-5-(3-chlorophenyl)-2,4-dihydro-3H-1,2,4- triazole-3-thione on the anticonvulsant action of different classical antiepileptic drugs in the mouse maximal electroshock-induced seizure model
J.J. Luszczki, T. Plech, and M. Wujec Effect of 4-(4-bromophenyl)-5-(3- chlorophenyl)-2,4-dihydro-3H-1,2,4-triazole-3-thione on the anticonvulsant action of different classical antiepileptic drugs in the mouse maximal electroshock-induced seizure model Eur. J. Pharmacol. 690 2012 99 106
Cyclization of the semicarbazone template of aryl semicarbazones: Synthesis and anticonvulsant activity of 4,5-diphenyl-2H-1,2,4-triazol-3(4H)-one
M. Shalini, P. Yogeeswari, D. Sriram, and J.P. Stables Cyclization of the semicarbazone template of aryl semicarbazones: synthesis and anticonvulsant activity of 4,5-diphenyl-2H-1,2,4-triazol-3(4H)-one Biomed. Pharmacother. 63 2009 187 193
Synthesis and anticonvulsant activity of new 2-substituted-5-[2-(2- fluorophenoxy)phenyl]-1,3,4-oxadiazoles and 1,2,4-triazoles
A. Almasirad, S.A. Tabatabai, M. Faizi, A. Kebriaeezadeh, N. Mehrabi, A. Dalvandi, and A. Shafiee Synthesis and anticonvulsant activity of new 2-substituted-5-[2-(2-fluorophenoxy)phenyl]-1,3,4-oxadiazoles and 1,2,4-triazoles Bioorg. Med. Chem. Lett. 14 2004 6057 6059
Synthesis, anticonvulsant and toxicity evaluation of 2-(1H-indol-3-yl) acetyl-N-(substituted phenyl)hydrazine carbothioamides and their related heterocyclic derivatives
N. Siddiqui, M.S. Alam, and W. Ahsan Synthesis, anticonvulsant and toxicity evaluation of 2-(1H-indol-3-yl)acetyl-N-(substituted phenyl)hydrazine carbothioamides and their related heterocyclic derivatives Acta Pharm. 58 2008 445 454
Triazole incorporated thiazoles as a new class of anticonvulsants: Design, synthesis and in vivo screening
N. Siddiqui, and W. Ahsan Triazole incorporated thiazoles as a new class of anticonvulsants: design, synthesis and in vivo screening Eur. J. Med. Chem. 45 2010 1536 1543
Synthesis and antimicrobial activity of thiosemicarbazides, s-triazoles and their Mannich bases bearing 3-chlorophenyl moiety
T. Plech, M. Wujec, A. Siwek, U. Kosikowska, and A. Malm Synthesis and antimicrobial activity of thiosemicarbazides, s-triazoles and their Mannich bases bearing 3-chlorophenyl moiety Eur. J. Med. Chem. 46 2011 241 248
Analysis of new potential anticonvulsant compounds in mice brain tissue by SPE/HPLC/DAD
J. Flieger, M. Pizoń, T. Plech, and J.J. Łuszczki Analysis of new potential anticonvulsant compounds in mice brain tissue by SPE/HPLC/DAD J. Chrom. B 909 2012 26 33
Chapter 16-the NIH anticonvulsant drug development (ADD) program: Preclinical anticonvulsant screening project
G. Avanzini, G. Regesta, P. Tanganelli, M. Avoli, John Libbey London
J.P. Stables, and H.J. Kupferberg Chapter 16-the NIH anticonvulsant drug development (ADD) program: preclinical anticonvulsant screening project G. Avanzini, G. Regesta, P. Tanganelli, M. Avoli, Molecular and Cellular Targets for Anti-epileptic Drugs 1997 John Libbey London
Une nouvelle méthode simple pour explorer l'action tranquilisante: Le test de la cheminée
J.R. Boissier, J. Tardy, and J.C. Diverres Une nouvelle méthode simple pour explorer l'action tranquilisante: le test de la cheminée Med. Exp. 3 1960 81 84
The role of technical, biological and pharmacological factors in the laboratory evaluation of anticonvulsant drugs IV. Protective indices
W. Löscher, and B. Nolting The role of technical, biological and pharmacological factors in the laboratory evaluation of anticonvulsant drugs IV. Protective indices Epilepsy Res. 9 1991 1 10
Anticonvulsant and acute neurotoxic effects of imperatorin, osthole and valproate in the maximal electroshock seizure and chimney tests in mice: A comparative study
J.J. Luszczki, E. Wojda, M. Andres-Mach, W. Cisowski, M. Glensk, K. Glowniak, and S.J. Czuczwar Anticonvulsant and acute neurotoxic effects of imperatorin, osthole and valproate in the maximal electroshock seizure and chimney tests in mice: a comparative study Epilepsy Res. 85 2009 293 299
